Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences with the insurer.

Cigna Group stock was falling sharply after the health insurer missed quarterly earnings estimates and issued light guidance amid higher medical costs. Cigna stock dropped 9% to $276 in premarket trading Thursday.

Cigna Group shares fell sharply after the health insurer reported fourth-quarter profit that was dragged down by medical costs, a trend that’s concerned investors in the sector for months.

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

Shares of Cigna Group slipped 6.70% to $282.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.53% to 6,071.17 and the Dow Jones Industrial Average rising 0.

UnitedHealth Group stock just saw its first insider buy of the year—and the first since the tragic murder of one of the healthcare company’s executives. UnitedHealth reported a mixed fourth-quarter report on Jan.

The number of victims impacted by the Change Healthcare data breach last year has nearly doubled, from 100 million to approximately 190 million, parent company UnitedHealth Group told TechCrunch last week.

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its customers amid widespread discontent with the healthcare system.

In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on Cigna (CI – Research Report), with a price target of

Cigna Group shares fell sharply after the health insurer reported fourth-quarter profit that was dragged down by medical costs, a trend that’s concerned investors in the sector for months. Most Read f

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 EPS, expectations were $7.84. Operator: Ladies and gentlemen, thank you for standing by for the Cigna Group’s Fourth Quarter 2024 Results Review.

Erin Wright, an analyst from Morgan Stanley, assigned the Buy rating on Cigna (CI – Research Report). The associated price target is